The Nervous System · Part Three · What the Rest of the Body Sends It
Lesson 48 / 61
Gluten and Food Sensitivity
When the gut speaks in antibodies, the brain answers in symptoms.
Gluten is the dietary protein whose gliadin fraction can breach the intestinal barrier and prime an immune cascade that reaches the brain, even in the absence of celiac disease. Through molecular mimicry, antibodies raised against gliadin cross-react with neural tissue, including cerebellar Purkinje cells. The gut and the immune system thereby become a second nervous system, conversing with the brain in the language of cytokines and antibodies.
Cross-reactive motif
Gliadin EQVPLVQQ vs cerebellar EDVPLLED
Tight-junction regulator
Zonulin (release raises permeability)
Antibody targets
Transglutaminase 6 and gliadin peptides
GFD symptom relief
74% reported relief (one cohort)
01THE BARRIER
A Wall One Cell Thick
The intestinal epithelium is a single layer of cells sealed by tight junctions, and gluten loosens that seal. The gliadin fraction of wheat triggers release of zonulin, the physiological regulator of the tight junction, and zonulin release raises paracellular permeability. Microbial fragments, undigested peptides, and antigens cross into the lamina propria where the immune system waits. Clinical neurochemistry treats this barrier as continuous with the blood-brain barrier, two gates of the same body. When one gate fails, inflammation does not stay local. It travels.
Gluten alters intestinal permeability, promotes oxidative stress, exerts cytotoxic and pro-inflammatory effects, and reshapes the microbiome. Cell apoptosis rises while differentiation falls. The wall meant to admit nutrients and exclude threats begins admitting both, and the body reads the breach as injury. This is the hyper-permeable state clinicians once called leaky gut, now understood as a paracellular translocation that primes a proinflammatory phenotype. The wall is one cell thick, and that single cell decides how much of the outside world the immune system must answer for.
02MIMICRY
The Cross-Reaction Gateway
Cross-reaction occurs when antibodies raised against one antigen bind a second antigen that merely resembles the first. Gliadin antibodies can cross-react with human tissue because short peptide sequences repeat across biology. Researchers comparing autism patients to controls found sequence similarity between the wheat gliadin antibody motif EQVPLVQQ and a cerebellar neural antibody motif EDVPLLED. The conclusion was direct. In a subgroup of patients, antibodies may be produced against both Purkinje cells and gliadin peptides, which could account for some neurological symptoms. The immune system, trained on food, mistakes the cerebellum for breakfast.
Molecular mimicry reframes food sensitivity as a neurological event. The same antibody that flags a dietary peptide can dock on transglutaminase 6, an enzyme expressed in the brain, or on the actomyosin network that also cross-reacts with Giardia and Entamoeba. This is why a single exposure can echo through circuits far from the gut. The cerebellum, dense with Purkinje cells and exquisitely sensitive to autoimmune attack, sits downstream of a meal. Gluten ataxia is the name given when that attack reaches movement, a reminder that the menu and the motor cortex share a correspondence.
03TRAFFICKING
Cytokines Cross the Gate
Inflammation in the gastrointestinal tract produces inflammation throughout the body and the brain by cytokine trafficking. Once the barrier loosens, signaling molecules released in the gut enter the circulation and reach the blood-brain barrier, where they shift the brain's inflammatory tone. This is the integrative pathway by which a dietary antigen becomes a mood, a migraine, a fog. The gut is not a passive tube. It is a sensory and immune organ that reports continuously to the central nervous system through humoral and vagal channels.
The clinical signature is broad because the trafficking is broad. Gluten ingestion has been linked to epilepsy, schizophrenia, autism spectrum disorder, multiple sclerosis, fibromyalgia, irritable bowel syndrome, migraine, depression, and progressive cognitive impairment, even where celiac disease is absent. A gluten-free diet brought significant relief to 74 percent of patients in one cohort. The lesson is not that one food explains every illness. It is that the immune conversation between gut and brain modulates the central integrative state of neurons, raising or lowering the baseline on which all perception and movement are built.
The ingestion of gluten seems to be related to disease even when there is no celiac disease, because the immune system reacts to food antigens and the resulting antibodies may attack the corresponding self-tissue, resulting in autoimmunity.
04THE PANEL
Reading the Cross-Reactors
Food sensitivity testing has evolved from proving a leaky gut to mapping which tissues an antibody might mistake. Clinicians stopped testing to confirm hyper-permeability because intestinal hyper-permeability is nearly universal. The more useful question is which cross-reactors are active. Gliadin shares motifs with casein, with buckwheat, amaranth, rice, corn, quinoa, and oats, and with viral antigens including Coxsackievirus, Rotavirus, Cytomegalovirus, and Rubella. A panel that reads these correspondences turns a vague intolerance into a map of risk. The antibody is the witness, and the panel is its testimony.
Transglutaminase 6 antibodies and gliadin-associated antibodies are the markers to reach for when neurology and diet intersect. In a 78-year-old case with a family history of ALS, the next best step included testing for both. The point is not to diagnose from a single value but to triangulate. Antibodies against glutamic acid decarboxylase appear across celiac disease, cerebellar ataxia, gluten sensitivity, stiff-person syndrome, and type 1 diabetes, a constellation that shows how one immune target ties metabolism, movement, and mood together. The panel does not cure. It clarifies what the body has already decided to fight.
05INTEGRATION
The Second Brain Reports
The gut, the immune system, and the brain form one continuous network rather than three separate organs. This is the integrative claim that organizes the whole picture. Food antigens enter through a loosened barrier, the immune system answers with antibodies, and those antibodies cross-react with self-tissue including neural structures. The microbiome shapes the immune set point, the vagus carries the visceral report upward, and cytokines tune the excitability of neurons far from the site of exposure. To change what reaches the brain, one can change what crosses the gut.
For the clinician this reframes food as a modulator of neural tone rather than a footnote to digestion. A 30-year-old with Hashimoto thyroiditis, severe depression, panic, fatigue, restless legs, and migraine, supposedly already gluten-free, illustrates how incomplete avoidance leaves the conversation open. The body keeps reacting because the antigen keeps arriving, by cross-reactor or by hidden exposure. Educationally, the system performs immune surveillance and the brain reads its results. The Nervous System hub treats this lesson as the bridge where neurochemistry meets the plate, where the milieu interieur of the gut sets terms the cerebellum must obey.